Liposomal vs. Conventional Bupivacaine for Pain Control

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The goal of this pilot study is to test the hypothesis that liposomal bupivacaine extends the duration of paravertebral block in patients undergoing radical nephrectomy, achieving improved analgesia compared to conventional bupivacaine. The main questions it aims to answer are: * Area under curve of numeric rating scale of pain from 12 to 72 h after surgery. * Cumulative opioid consumption during the period of 12 to 72 h after surgery.
Epistemonikos ID: 98aa7e4daa766822052258a0d163885570747827
First added on: May 15, 2024